---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-049951"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2024-12-04T23:59:59+00:00"
generated_at: "2026-05-29T08:29:57.511535+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ChromaDex obtains waiver of ~$3.5M in accrued royalties from Dartmouth contingent on appeal bond in Elysium case

## Summary
- Dartmouth waives ~$3.5M in accrued unpaid royalties, license fees, and maintenance expenses under exclusive license agreements.
- Waiver contingent on ChromaDex securing an Appeal Bond for fee judgment in Delaware patent infringement case against Elysium Health.
- ChromaDex executed the Appeal Bond as of December 3, 2024; plans to move to stay execution of fee judgment pending appeal.
- No further royalties or payments will be owed to Dartmouth for the licensed patents after effective date of Supplemental Agreement.
- Supplemental Agreement supplements prior exclusive license agreements from 2012 and 2014 for Dartmouth-owned U.S. patents.

## SEC filing metadata
- accession: 0001628280-24-049951
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2024-12-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828024049951/0001628280-24-049951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828024049951/cdxc-20241204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-049951
- JSON: https://secwatch.observer/filing/0001628280-24-049951.json
- Plain text: https://secwatch.observer/filing/0001628280-24-049951.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.